Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
Status:
Completed
Trial end date:
2014-11-04
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of dexamethasone intravitreal implant
(Ozurdex®) compared to ranibizumab (Lucentis®) in patients with branch retinal vein occlusion
(BRVO).